In October, Boston Healthcare connected with the innovators of AI-enabled companies at the AI in Healthcare Conference. Use cases for AI in healthcare were presented, along with some of the barriers to adoption that still exist.
In a proposed rule issued last week, the Centers for Medicare & Medicaid Services (CMS) took action to build upon the Administration’s efforts to lower drug costs and reduce out-of-pocket costs for patients.
Team members at Boston Healthcare attended the annual Digital Healthcare Innovation Summit, a meeting place for innovators, investors, payers, providers, policymakers, and advisors to discuss the current state of and future expectations for digital health. Read our overview here.
The Diagnostic Accuracy and Innovation Act (DAIA), introduced last year in the House of Representatives, would allow the Food and Drug Administration (FDA) to regulate laboratory developed tests with a new category of in vitro clinical tests (IVCTs).
Germany has introduced two different approaches to increase digital health access for patients, providers, and health insurance companies, the Electronic Health Card Network and the Patient Accessible Electronic Health Records.